Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Research

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy

Authors: Yan-jiao Cheng, Miao Wang, Jia Wang, Zhao Cui, Ming-hui Zhao

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background

Most primary membranous nephropathy (MN) is mediated by anti-phospholipase A2 receptor (PLA2R) antibodies. Recently, these antibodies have been revealed months to years before the disease's onset. Their production and pathogenicity need further investigation.

Methods

Anti-PLA2R antibodies were purified from plasma of eight healthy individuals, 12 patients with PLA2R-related MN and negative circulating antibody (Ab-), and 18 patients with positive anti-PLA2R antibodies (Ab +), using affinity column coupled with recombinant human PLA2R. The antigen specificity, antibody amount, titer, IgG subclass, and affinity were assessed by Western blot, immunofluorescence, ELISA, and surface plasmon resonance.

Results

The natural anti-PLA2R antibodies recognized the conformational structure of PLA2R which locates on the cell membrane of podocytes. The amount of natural IgG was 0.12 ± 0.04 g/L, which accounted for 0.80% of total IgG and was lower than that of patients (2.36%, P < 0.001). The titer of natural antibodies was lower than that of patients in Ab- and Ab + groups (1:16 vs. 1:43 vs. 1:274, P < 0.001). IgG2(45.1%) was predominant in natural antibodies, while IgG4 was predominant in Ab + group (45.7 vs. 25.0%, P < 0.001). IgG1 was increasing from natural antibodies to Ab- and Ab + groups. The affinity of natural antibodies was lower than that of patients (KD: 641.0 vs. 269.0 vs. 99.6 nM, P = 0.002). The antibody titer, affinity, and IgG4 percentage were associated with the severity of proteinuria and the stages of membranous lesion.

Conclusions

The natural anti-PLA2R antibodies exist in healthy plasma. The antibody titer, IgG subclass, and affinity may participate in the pathogenesis of anti-PLA2R antibodies.
Literature
1.
go back to reference Ronco P, Debiec H. Membranous nephropathy: current understanding of various causes in light of new target antigens. Curr Opin Nephrol Hypertens. 2021;30(3):287–93.CrossRefPubMedPubMedCentral Ronco P, Debiec H. Membranous nephropathy: current understanding of various causes in light of new target antigens. Curr Opin Nephrol Hypertens. 2021;30(3):287–93.CrossRefPubMedPubMedCentral
2.
go back to reference Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A(sub 2) receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21.CrossRefPubMedPubMedCentral Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A(sub 2) receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21.CrossRefPubMedPubMedCentral
3.
go back to reference Meyer-Schwesinger C, Tomas NM, Dehde S, Seifert L, Hermans-Borgmeyer I, Wiech T, et al. A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients. Kidney Int. 2020;97(5):913–9.CrossRefPubMed Meyer-Schwesinger C, Tomas NM, Dehde S, Seifert L, Hermans-Borgmeyer I, Wiech T, et al. A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients. Kidney Int. 2020;97(5):913–9.CrossRefPubMed
4.
go back to reference Ruggenenti P, Fervenza FC, Remuzzi G. Treatment of membranous nephropathy: time for a paradigm shift. Nat Rev Nephrol. 2017;13(9):563–79.CrossRefPubMed Ruggenenti P, Fervenza FC, Remuzzi G. Treatment of membranous nephropathy: time for a paradigm shift. Nat Rev Nephrol. 2017;13(9):563–79.CrossRefPubMed
5.
go back to reference Hofstra JM, Beck LH, Beck DM, Wetzels JF, Salant DJ. Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6(6):1286–91.CrossRefPubMedPubMedCentral Hofstra JM, Beck LH, Beck DM, Wetzels JF, Salant DJ. Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6(6):1286–91.CrossRefPubMedPubMedCentral
6.
go back to reference Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RAK. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol. 2014;25(6):1357–66.CrossRefPubMedPubMedCentral Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RAK. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol. 2014;25(6):1357–66.CrossRefPubMedPubMedCentral
7.
go back to reference Ruggenenti P, Debiec H, Ruggiero B, Chianca A, Pelle T, Gaspari F, et al. Anti-phospholipase A(2) receptor antibody titer predicts post-rituximab outcome of membranous nephropathy. J Am Soc Nephrol. 2015;26(10):2545–58.CrossRefPubMedPubMedCentral Ruggenenti P, Debiec H, Ruggiero B, Chianca A, Pelle T, Gaspari F, et al. Anti-phospholipase A(2) receptor antibody titer predicts post-rituximab outcome of membranous nephropathy. J Am Soc Nephrol. 2015;26(10):2545–58.CrossRefPubMedPubMedCentral
8.
go back to reference Beck LH, Fervenza FC, Beck DM, Bonegio RGB, Malik FA, Erickson SB, et al. Rituximab-induced depletion of anti-PLA(2)R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol. 2011;22(8):1543–50.CrossRefPubMedPubMedCentral Beck LH, Fervenza FC, Beck DM, Bonegio RGB, Malik FA, Erickson SB, et al. Rituximab-induced depletion of anti-PLA(2)R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol. 2011;22(8):1543–50.CrossRefPubMedPubMedCentral
9.
go back to reference Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, et al. Rituximab for severe membranous nephropathy: A 6-month trial with extended follow-up. J Am Soc Nephrol. 2017;28(1):348–58.CrossRefPubMed Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, et al. Rituximab for severe membranous nephropathy: A 6-month trial with extended follow-up. J Am Soc Nephrol. 2017;28(1):348–58.CrossRefPubMed
10.
go back to reference Seitz-Polski B, Dolla G, Payre C, Girard CA, Polidori J, Zorzi K, et al. Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy. J Am Soc Nephrol. 2016;27(5):1517–33.CrossRefPubMed Seitz-Polski B, Dolla G, Payre C, Girard CA, Polidori J, Zorzi K, et al. Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy. J Am Soc Nephrol. 2016;27(5):1517–33.CrossRefPubMed
11.
go back to reference Reinhard L, Zahner G, Menzel S, Koch-Nolte F, Stahl RAK, Hoxha E. Clinical relevance of domain-specific phospholipase A2 receptor 1 antibody levels in patients with membranous nephropathy. J Am Soc Nephrol. 2020;31(1):197–207.CrossRefPubMed Reinhard L, Zahner G, Menzel S, Koch-Nolte F, Stahl RAK, Hoxha E. Clinical relevance of domain-specific phospholipase A2 receptor 1 antibody levels in patients with membranous nephropathy. J Am Soc Nephrol. 2020;31(1):197–207.CrossRefPubMed
15.
go back to reference Cui Z, Wang H, Zhao M. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int. 2006;69(5):894–9.CrossRefPubMed Cui Z, Wang H, Zhao M. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int. 2006;69(5):894–9.CrossRefPubMed
16.
go back to reference Cui Z, Zhao M, Segelmark M, Hellmark T. Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int. 2010;78(6):590–7.CrossRefPubMed Cui Z, Zhao M, Segelmark M, Hellmark T. Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int. 2010;78(6):590–7.CrossRefPubMed
17.
go back to reference Bouanani M, Bataille R, Piechaczyk M, Salhi SL, Pau B, Bastide M. Autoimmunity to human thyroglobulin: Respective epitopic specificity patterns of anti-human thyroglobulin autoantibodies in patients with sjögren’s syndrome and patients with hashimoto’s thyroiditis. Arthritis Rheum. 2010;34(12):1585–93.CrossRef Bouanani M, Bataille R, Piechaczyk M, Salhi SL, Pau B, Bastide M. Autoimmunity to human thyroglobulin: Respective epitopic specificity patterns of anti-human thyroglobulin autoantibodies in patients with sjögren’s syndrome and patients with hashimoto’s thyroiditis. Arthritis Rheum. 2010;34(12):1585–93.CrossRef
18.
go back to reference Ichiyoshi Y, Zhou M, Casali P. A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin-specific “germ-line” natural antibody template analysis by V gene segment reassortment and site-directed mutagenesis. J Immunol Baltim Md. 1995;154(1):226–38. Ichiyoshi Y, Zhou M, Casali P. A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin-specific “germ-line” natural antibody template analysis by V gene segment reassortment and site-directed mutagenesis. J Immunol Baltim Md. 1995;154(1):226–38.
19.
go back to reference Witte T, Hartung K, Sachse C, Matthias T, Fricke M, Deicher H, et al. IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. Rheumatol Int. 1998;18(3):85–91.CrossRefPubMed Witte T, Hartung K, Sachse C, Matthias T, Fricke M, Deicher H, et al. IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. Rheumatol Int. 1998;18(3):85–91.CrossRefPubMed
20.
go back to reference Watanabe K, Watanabe K, Watanabe Y, Fujioka D, Nakamura T, Nakamura K, et al. Human soluble phospholipase A2 receptor is an inhibitor of the integrin-mediated cell migratory response to collagen-I. Am J Physiol Cell Physiol. 2018;315(3):C398-408.CrossRefPubMed Watanabe K, Watanabe K, Watanabe Y, Fujioka D, Nakamura T, Nakamura K, et al. Human soluble phospholipase A2 receptor is an inhibitor of the integrin-mediated cell migratory response to collagen-I. Am J Physiol Cell Physiol. 2018;315(3):C398-408.CrossRefPubMed
21.
go back to reference Fresquet M, Jowitt TA, McKenzie EA, Ball MD, Randles MJ, Lennon R, et al. PLA2R binds to the annexin A2–S100A10 complex in human podocytes. Sci Rep. 2017;7(1):6876.CrossRefPubMedPubMedCentral Fresquet M, Jowitt TA, McKenzie EA, Ball MD, Randles MJ, Lennon R, et al. PLA2R binds to the annexin A2–S100A10 complex in human podocytes. Sci Rep. 2017;7(1):6876.CrossRefPubMedPubMedCentral
22.
go back to reference Burbelo PD, Joshi M, Chaturvedi A, Little DJ, Thurlow JS, Waldman M, et al. Detection of PLA2R autoantibodies before the diagnosis of membranous nephropathy. J Am Soc Nephrol. 2020;31(1):208–17.CrossRefPubMed Burbelo PD, Joshi M, Chaturvedi A, Little DJ, Thurlow JS, Waldman M, et al. Detection of PLA2R autoantibodies before the diagnosis of membranous nephropathy. J Am Soc Nephrol. 2020;31(1):208–17.CrossRefPubMed
23.
go back to reference Huang J, Liu G, Zhang Y, Cui Z, Wang F, Liu X, et al. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis. BMC Med. 2014;12:81.CrossRefPubMedPubMedCentral Huang J, Liu G, Zhang Y, Cui Z, Wang F, Liu X, et al. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis. BMC Med. 2014;12:81.CrossRefPubMedPubMedCentral
24.
go back to reference Ancian P, Lambeau G, Mattéi M-G, Lazdunski M. The human 180-kDa receptor for secretory phospholipases A2. J Biol Chem. 1995;270(15):8963–70.CrossRefPubMed Ancian P, Lambeau G, Mattéi M-G, Lazdunski M. The human 180-kDa receptor for secretory phospholipases A2. J Biol Chem. 1995;270(15):8963–70.CrossRefPubMed
25.
go back to reference Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol. 2003;21(1):139–76.CrossRefPubMed Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol. 2003;21(1):139–76.CrossRefPubMed
26.
go back to reference Kaveri SV, Silverman GJ, Bayry J. Natural IgM in immune equilibrium and harnessing their therapeutic potential. J Immunol. 2012;188(3):939–45.CrossRefPubMed Kaveri SV, Silverman GJ, Bayry J. Natural IgM in immune equilibrium and harnessing their therapeutic potential. J Immunol. 2012;188(3):939–45.CrossRefPubMed
27.
go back to reference Hayakawa K, Asano M, Shinton SA, Gui M, Allman D, Stewart CL, et al. Positive selection of natural autoreactive B cells. Science. 1999;285(5424):113–6.CrossRefPubMed Hayakawa K, Asano M, Shinton SA, Gui M, Allman D, Stewart CL, et al. Positive selection of natural autoreactive B cells. Science. 1999;285(5424):113–6.CrossRefPubMed
28.
go back to reference Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, et al. Amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease patients treated with bapineuzumab: a retrospective analysis. Lancet Neurol. 2012;11(3):241–9.CrossRefPubMedPubMedCentral Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, et al. Amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease patients treated with bapineuzumab: a retrospective analysis. Lancet Neurol. 2012;11(3):241–9.CrossRefPubMedPubMedCentral
29.
go back to reference Nagele EP, Han M, Acharya NK, DeMarshall C, Kosciuk MC, Nagele RG. Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease. PLoS ONE. 2013;8(4): e60726.CrossRefPubMedPubMedCentral Nagele EP, Han M, Acharya NK, DeMarshall C, Kosciuk MC, Nagele RG. Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease. PLoS ONE. 2013;8(4): e60726.CrossRefPubMedPubMedCentral
30.
go back to reference Xu X, Wang GB, Chen N, Lu T, Nie S, Xu G, et al. Long-term exposure to air pollution and increased risk of membranous nephropathy in China. J Am Soc Nephrol. 2016;27(12):3739–46.CrossRefPubMedPubMedCentral Xu X, Wang GB, Chen N, Lu T, Nie S, Xu G, et al. Long-term exposure to air pollution and increased risk of membranous nephropathy in China. J Am Soc Nephrol. 2016;27(12):3739–46.CrossRefPubMedPubMedCentral
31.
go back to reference Pfau JC, Brown JM, Holian A. Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology. 2004;195(2–3):167–76.CrossRefPubMed Pfau JC, Brown JM, Holian A. Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology. 2004;195(2–3):167–76.CrossRefPubMed
32.
go back to reference Thompson AMS, Zanobetti A, Silverman F, Schwartz J, Coull B, Urch B, et al. baseline repeated measures from controlled human exposure studies: associations between ambient air pollution exposure and the systemic inflammatory biomarkers IL-6 and fibrinogen. Environ Health Perspect. 2010;118(1):120–4.CrossRefPubMed Thompson AMS, Zanobetti A, Silverman F, Schwartz J, Coull B, Urch B, et al. baseline repeated measures from controlled human exposure studies: associations between ambient air pollution exposure and the systemic inflammatory biomarkers IL-6 and fibrinogen. Environ Health Perspect. 2010;118(1):120–4.CrossRefPubMed
33.
go back to reference Panasevich S, Leander K, Rosenlund M, Ljungman P, Bellander T, de Faire U, et al. Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sample. Occup Environ Med. 2009;66(11):747–53.CrossRefPubMed Panasevich S, Leander K, Rosenlund M, Ljungman P, Bellander T, de Faire U, et al. Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sample. Occup Environ Med. 2009;66(11):747–53.CrossRefPubMed
34.
go back to reference Yokota Y, Ikeda M, Higashino K, Nakano K, Fujii N, Arita H, et al. Enhanced tissue expression and elevated circulating level of phospholipase A2 receptor during murine endotoxic shock. Arch Biochem Biophys. 2000;379(1):7–17.CrossRefPubMed Yokota Y, Ikeda M, Higashino K, Nakano K, Fujii N, Arita H, et al. Enhanced tissue expression and elevated circulating level of phospholipase A2 receptor during murine endotoxic shock. Arch Biochem Biophys. 2000;379(1):7–17.CrossRefPubMed
36.
go back to reference Huang CC, Lehman A, Albawardi A, Satoskar A, Brodsky S, Nadasdy G, et al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol. 2013;26(6):799–805.CrossRefPubMed Huang CC, Lehman A, Albawardi A, Satoskar A, Brodsky S, Nadasdy G, et al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol. 2013;26(6):799–805.CrossRefPubMed
37.
go back to reference Obana M, Nakanishi K, Sako M, Yata N, Nozu K, Tanaka R, et al. Segmental membranous glomerulonephritis in children: comparison with global membranous glomerulonephritis. Clin J Am Soc Nephrol. 2006;1(4):723–9.CrossRefPubMed Obana M, Nakanishi K, Sako M, Yata N, Nozu K, Tanaka R, et al. Segmental membranous glomerulonephritis in children: comparison with global membranous glomerulonephritis. Clin J Am Soc Nephrol. 2006;1(4):723–9.CrossRefPubMed
38.
go back to reference Fresquet M, Jowitt TA, Gumnnadova J, Collins R, O’Cualain R, McKenzie EA, et al. Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy. J Am Soc Nephrol. 2015;26(2):302–13.CrossRefPubMed Fresquet M, Jowitt TA, Gumnnadova J, Collins R, O’Cualain R, McKenzie EA, et al. Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy. J Am Soc Nephrol. 2015;26(2):302–13.CrossRefPubMed
39.
go back to reference Kao LY, Lam V, Waldman M, Glassock RJ, Zhu QS. Identification of the immunodominant epitope region in phospholipase A(2) receptor-mediating autoantibody binding in idiopathic membranous nephropathy. J Am Soc Nephrol. 2015;26(2):291–301.CrossRefPubMed Kao LY, Lam V, Waldman M, Glassock RJ, Zhu QS. Identification of the immunodominant epitope region in phospholipase A(2) receptor-mediating autoantibody binding in idiopathic membranous nephropathy. J Am Soc Nephrol. 2015;26(2):291–301.CrossRefPubMed
Metadata
Title
The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
Authors
Yan-jiao Cheng
Miao Wang
Jia Wang
Zhao Cui
Ming-hui Zhao
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01096-5

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue